Renal Cancers Withdrawn Phase 2 Trials for Sunitinib (DB01268)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03035630Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell CarcinomaTreatment